John Geisler Email

Founder & CSO . Mitochon Pharmaceuticals

Current Roles

Employees:
5
Revenue:
$775k
About
Mitochon Pharmaceuticals is a start-up biotech company, formed in 2014, that focuses on developing drugs that target the mitochondria for a host of serious diseases with significant unmet medical needs. Our development programs are primarily focused on neurodegenerative & neuromuscular diseases including: Huntington’s, Multiple Sclerosis, Epilepsy, Autism, Rett Syndrome, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer’s Disease, Parkinson Disease and severe burns, and secondarily on metabolic disorders due to over-nutrition (diabetes, obesity and NASH). On-going research has linked these diseases to various malfunctions of the mitochondria. By correcting them, Mitochon aims at opening the way for a broad range of disease modifying therapies. Mitochon is led by a team of industry executives with over 80-years of combined experience and a passion to bring forward breakthrough drug therapies for a host of devastating diseases.
Mitochon Pharmaceuticals Address
970 Cross Lane
Blue Bell, PA
Mitochon Pharmaceuticals Email
Mitochon Pharmaceuticals Phone Numbers
610-225-6200

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.